Every year, we’re seeing amazing advances in adult stem cell research. It’s been used to treat multiple sclerosis, repair cartilage damage, and grow new corneas to restore sight for blind patients. It’s showing significant promise to successfully treat spinal cord injury, breast cancer, Type 1 diabetes, and heart disease. These are life altering diseases that, if cured, can make a difference in the lives of individual Americans, accelerate our understanding of chronic conditions, and catapult America’s global competitiveness.
Adult stem cells are non-embryonic and noncontroversial, taken from a live human being through umbilical cord blood, bone marrow, and other tissues, and used to regenerate and repair tissues and organs. The science is amazing, and many scientists, researchers, and medical doctors agree that adult stem cells can be a successful method for treating patients.
With the Patients First Act, H.R. 2921 we could see results even faster.This bipartisan legislation would prioritize stem cell research that has the greatest potential for near-term clinical benefits. It prioritizes funding for promising stem cell research without authorizing any new spending. It streamlines our investment so our research dollars are going further, providing the most benefit to patients in the most efficient manner possible.
